BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13489181)

  • 1. The antagonism of the vascular effects of 5-hydroxytryptamine by BOL 148 and sodium salicylate in the human subject.
    GLOVER WE; MARSHALL RJ; WHELAN RF
    Br J Pharmacol Chemother; 1957 Dec; 12(4):498-503. PubMed ID: 13489181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition by sodium salicylate of oedema of the hind-paw of the rat induced by 5-hydroxytryptamine.
    KELEMEN E
    Br J Pharmacol Chemother; 1957 Mar; 12(1):28-9. PubMed ID: 13413147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of 5-hydroxytryptamine on the blood vessels of the human hand and forearm.
    RODDIE IC; SHEPHERD JT; WHELAN RF
    Br J Pharmacol Chemother; 1955 Dec; 10(4):445-50. PubMed ID: 13276601
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of lysergic acid diethylamide (LSD 25), its 2-brom derivative (BOL 148) and of 5-hydroxytryptamine (5-HT) on the peristaltic reflex of the guinea-pig ileum.
    GINZEL KH
    J Physiol; 1957 Jul; 137(2):62P-3. PubMed ID: 13449894
    [No Abstract]   [Full Text] [Related]  

  • 10. [Facilitation of the venoconstrictor action of 5-hydroxytryptamine by ergotamine, methysergide and LSD-25 in humans].
    Fanciullacci M; Franchi G; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Apr; 51(8):517-22. PubMed ID: 1212344
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.
    SALMOIRAGHI GC; SOLLERO L; PAGE IH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558
    [No Abstract]   [Full Text] [Related]  

  • 12. Is 2-bromo-D-lysergic acid diethylamide (BOL) an allosteric antagonist of serotonergic receptors in rabbit atria?
    Xu Z; Purdy RE
    Proc West Pharmacol Soc; 1988; 31():181-3. PubMed ID: 2905465
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of intraventricular injection of d-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat.
    BRADLEY PB; HANCE AJ
    J Physiol; 1956 May; 132(2):50-1P. PubMed ID: 13320431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of courses of acetylsalicylic acid and sodium salicylate administration on the carbohydrate-phosphorus metabolic indices in vascular tissue].
    Riabkov AN
    Farmakol Toksikol; 1985; 48(3):80-3. PubMed ID: 4029385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulatory effects of salicylates.
    WALTON RP; DARBY TD
    Circ Res; 1958 Mar; 6(2):155-8. PubMed ID: 13511668
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex.
    BULBRING E; CREMA A
    Br J Pharmacol Chemother; 1958 Dec; 13(4):444-57. PubMed ID: 13618550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.
    Xu Z; Purdy RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1091-5. PubMed ID: 2564889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.